Plus therapeutics announces oral presentation at the society of nuclear medicine and molecular imaging (snmmi) 2022 annual meeting

Austin, texas, april 19, 2022 (globe newswire) -- plus therapeutics, inc. (nasdaq: pstv) (the “company”), a clinical-stage pharmaceutical company developing innovative, targeted radiotherapeutics for rare and difficult-to-treat cancers, today announced that it will discuss new data in an oral presentation at the society of nuclear medicine and molecular imaging (snmmi) 2022 annual meeting, being held june 11-14, 2022, in vancouver, british columbia, canada.
pstv Ratings Summary
pstv Quant Ranking